VTVT stock

vTv Therapeutics Inc (VTVT) stock news · $133.9M cap

vTv Therapeutics Inc (VTVT) is a biotechnology company listed on NASDAQ.

This VTVT news page leads with what vTv Therapeutics Inc filed — not a scraped headline mill.

No cached 8-K sentence for VTVT yet. We will not pad this page with generic market recap.

Latest reported VTVT revenue for 2025-12-31 was $0. Net income was -$27.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. VTVT currently screens at market cap $133.9M.

EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.

Not investment advice. For the model open the VTVT stock page; for the tape open the quote page.

VTVT stock news FAQ

What is VTVT's latest net income?

Latest cached vTv Therapeutics Inc (VTVT) net income was -$27.0M. Statements: https://lician.com/financials/vtvt

What is VTVT's market cap?

vTv Therapeutics Inc (VTVT) market cap is $133.9M on the latest cached fundamentals snapshot.

What kind of company is VTVT?

vTv Therapeutics Inc (VTVT) is a biotechnology company listed on NASDAQ.

Where is VTVT stock news listed?

Cached stock news for vTv Therapeutics Inc (VTVT) is listed at https://lician.com/news/vtvt. Filings: https://lician.com/sec/vtvt

Not investment advice.

Full VTVT analysis